Cambios significativos en el manejo y control del HIV/sida

Sharp PM, Hahn BH. Origins of HIV and the AIDS pandemic. Cold Spring Harb Perspect Med. 2011;1:a006841. https://doi.org/10.1101/cshperspect.a006841

Gilbert MT, Rambaut A, Wlasiuk G, Spira TJ, Pitchenik AE, Worobey M. The emergence of HIV/AIDS in the Americas and beyond. Proc Natl Acad Sci U S A. 2007;104:18566-70. https://doi.org/10.1073/pnas.0705329104

Simelela N, Venter WD, Pillay Y, Barron P. A political and social history of HIV in South Africa. Curr HIV/AIDS Rep. 2015;12:256-61. https://doi.org/10.1007/s11904-015-0259-7

Bor J, Rosen S, Chimbindi N, Haber N, Herbst K, Mutevedzi T, et al. Mass HIV treatment and sex disparities in life expectancy: Demographic surveillance in rural South Africa. PLoS Med. 2015;12:e1001905. https://doi.org/10.1371/journal.pmed.1001905

Fondo Colombiano de Enfermedades de Alto Costo. Sitación del VIH Sida en Colombia 2017. Fecha de consulta: 13 de marzo de 2019. Disponible en: https://cuentadealtocosto.org/site/images/Publicaciones/2018/Situacion_VIH_2017.pdf

Fulop T, Herbein G, Cossarizza A, Witkowski JM, Frost E, Dupuis G, et al. Cellular senescence, immunosenescence and HIV. Interdiscip Top Gerontol Geriatr. 2017;42:28-46. https://doi.org/10.1159/000448542

da Cunha J, Maselli LM, Stern AC, Spada C, Bydlowski SP. Impact of antiretroviral therapy on lipid metabolism of human immunodeficiency virus-infected patients: Old and new drugs. World J Virol. 2015;4:56-77. https://doi.org/10.5501/wjv.v4.i2.56

Haser GC, Sumpio B. Systemic and cell-specific mechanisms of vasculopathy induced by human immunodeficiency virus and highly active antiretroviral therapy. J Vasc Surg. 2017;65: 849-59. https://doi.org/10.1016/j.jvs.2016.01.036

Thrift AP, Chiao EY. Are non-HIV malignancies increased in the HIV-infected population? Curr Infect Dis Rep. 2018;20:22. https://doi.org/10.1007/s11908-018-0626-9

Hogg RS, Eyawo O, Collins AB, Zhang W, Jabbari S, Hull MW, et al. Health-adjusted life expectancy in HIV-positive and HIV-negative men and women in British Columbia, Canada: A population-based observational cohort study. Lancet HIV. 2017;4: e270-6. https://doi.org/10.1016/S2352-3018(17)30029-2

Smith JM, Flexner C. The challenge of polypharmacy in an aging population and implications for future antiretroviral therapy development. AIDS. 2017;31(Suppl.2): S173-84. https://doi.org/10.1097/QAD.0000000000001401

Prins HAB, Verbon A, Boucher CAB, Rokx C. Ending the epidemic: Critical role of primary HIV infection. Neth J Med. 2017;75:321-7.

Lynch NG, Johnson AK. Congenital HIV: Prevention of maternal to child transmission. Adv Neonatal Care. 2018;18:330-40. https://doi.org/10.1097/ANC.0000000000000559

Koechlin FM, Fonner VA, Dalglish SL, O’Reilly KR, Baggaley R, Grant RM, et al. Values and preferences on the use of oral pre-exposure prophylaxis (PrEP) for HIV prevention among multiple populations: A systematic review of the literature. AIDS Behav. 2017;21:1325-35. https://doi.org/10.1007/s10461-016-1627-z

Shubber Z, Mills EJ, Nachega JB, Vreeman R, Freitas M, Bock P, et al. Patient- reported barriers to adherence to antiretroviral therapy: A systematic review and meta-analysis. PLoS Med. 2016;13:e1002183. https://doi.org/10.1371/journal.pmed.1002183

Bezabhe WM, Chalmers L, Bereznicki LR, Peterson GM. Adherence to antiretroviral therapy and virologic failure: A meta-analysis. Medicine (Baltimore). 2016;95:e3361. https://doi.org/10.1097/MD.0000000000003361

Hutter G, Nowak D, Mossner M, Ganepola S, Mussig A, Allers K, et al. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med. 2009;360:692-8. https://doi.org/10.1056/NEJMoa0802905

Gupta RK, Abdul-Jawad S, McCoy LE, Mok HP, Peppa D, Salgado M, et al. HIV-1 remission following CCR5Delta32/Delta32 haematopoietic stem-cell transplantation. Nature 2019;568: 244-8. https://doi.org/10.1038/s41586-019-1027-4